These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30226290)

  • 21. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.
    Rektorova I; Srovnalova H; Kubikova R; Prasek J
    Mov Disord; 2008 Aug; 23(11):1580-7. PubMed ID: 18618663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings.
    Gigante AF; Defazio G; Niccoli Asabella A; Superbo M; Ferrari C; Liuzzi D; Iliceto G; Livrea P; Rubini G
    Acta Neurol Scand; 2016 Oct; 134(4):265-70. PubMed ID: 26659996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder.
    van Enkhuizen J; Henry BL; Minassian A; Perry W; Milienne-Petiot M; Higa KK; Geyer MA; Young JW
    Neuropsychopharmacology; 2014 Dec; 39(13):3112-22. PubMed ID: 25005251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
    Chung SJ; Lee YH; Yoo HS; Sohn YH; Ye BS; Cha J; Lee PH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1652-1660. PubMed ID: 30980099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels.
    Voon V; Rizos A; Chakravartty R; Mulholland N; Robinson S; Howell NA; Harrison N; Vivian G; Ray Chaudhuri K
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):148-52. PubMed ID: 23899625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
    Kübler D; Schroll H; Buchert R; Kühn AA
    J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
    Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impulsivity is related to striatal dopamine transporter availability in healthy males.
    Costa A; la Fougère C; Pogarell O; Möller HJ; Riedel M; Ettinger U
    Psychiatry Res; 2013 Mar; 211(3):251-6. PubMed ID: 23158972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.
    Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
    Nucl Med Commun; 2005 May; 26(5):421-6. PubMed ID: 15838424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Greater striatal dopamine transporter density may be associated with major depressive episode.
    Amsterdam JD; Newberg AB; Soeller I; Shults J
    J Affect Disord; 2012 Dec; 141(2-3):425-31. PubMed ID: 22482744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
    Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y
    Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers--a SPECT study.
    Chen PS; Yeh TL; Lee IH; Lin CB; Tsai HC; Chen KC; Chiu NT; Yao WJ; Yang YK; Chou YH
    Neuroimage; 2011 Jun; 56(3):1526-30. PubMed ID: 21371559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
    Booij J; Speelman JD; Horstink MW; Wolters EC
    Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistry.
    Depboylu C; Maurer L; Matusch A; Hermanns G; Windolph A; Béhé M; Oertel WH; Höglinger GU
    Neuroimage; 2013 Oct; 79():191-200. PubMed ID: 23631981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism.
    Lee YH; Lee S; Chung SJ; Yoo HS; Jung JH; Baik K; Ye BS; Sohn YH; Yun M; Lee PH
    Parkinsonism Relat Disord; 2021 Jan; 82():1-6. PubMed ID: 33220520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers.
    van de Giessen E; Hesse S; Caan MW; Zientek F; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Guignard R; Akdemir UO; Knudsen GM; Nobili F; Pagani M; Vander Borght T; Van Laere K; Varrone A; Tatsch K; Booij J; Sabri O
    Neuroimage; 2013 Jan; 64():61-7. PubMed ID: 22982354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between the striatal dopamine transporter and novelty seeking and cognitive flexibility in opioid dependence.
    Liang CS; Ho PS; Yen CH; Chen CY; Kuo SC; Huang CC; Yeh YW; Ma KH; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Mar; 74():36-42. PubMed ID: 27940252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
    Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.